Starting July 1, credit-reporting giants will remove certain medical debts; AstraZeneca’s Evusheld was shown to reduce the viral load of subvariants BA.1, BA1.1, and BA.2; about 4% of middle school students and 13% of high school students use some type of tobacco product, according to a report.
Credit-reporting giants Equifax, Experian and TransUnion announced Friday they will remove credit stains created by certain medical debts starting July 1, 2022. As reported by The New York Times, these changes include removing black marks for people who paid their medical debt after it went to collections and having new unpaid medical debts appear a full year after being sent to collections rather than 6 months after. Starting in 2023, the companies will also exclude unpaid medical debts less than $500. According to the credit-reporting companies, these changes will remove up to 70% of medical debts currently affecting consumers’ credit reports and scores.
AstraZeneca said Monday its COVID-19 antibody treatment, Evusheld, neutralized Omicron variants in an independent study, Reuters reported. The study—which has yet to be peer reviewed—showed that Evusheld reduced the viral load of subvariants BA.1, BA1.1, and BA.2, and limited lung inflammation. Evusheld is a combination monoclonal antibody treatment of tixagevimab and cilgavimab and has received FDA emergency use authorization but is not yet approved.
According to findings from the 2021 National Youth Tobacco Survey, 2.55 million middle school and high school students in the United States use some type of tobacco product, equating to about 4% of middle school students and 13% of high school students. As reported by The Washington Post, these data include the use of electronic, smokeless, and combustible products, and were collected from a nationally representative sample of more than 20,000 students from 279 public and private schools. E-cigarettes were the most commonly used product, with students citing curiosity and peer pressure for the reasons they began using them, and crediting them for helping to deal with anxiety, stress, and depression. However, smoking tobacco in general has been shown to lead to a wide range of negative health effects and is described as the leading cause of preventable deaths.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Methotrexate May Lower Blood Pressure in Rheumatoid Arthritis
September 4th 2025Methotrexate significantly lowered systolic blood pressure compared with sulfasalazine in adults with newly diagnosed rheumatoid arthritis, suggesting potential cardiovascular benefits beyond its anti-inflammatory effects.
Read More
Prevention, Early Intervention Highlighted in Updated High Blood Pressure Guidelines
September 4th 2025A new joint guideline from the American Heart Association and the American College of Cardiology emphasizes early treatment, close perinatal blood pressure monitoring, and incorporating the PREVENT risk calculator to personalize care.
Read More